Redeye updates its view on Verve Group following its Q3 2024 report, which showed strong growth, as ...
Redeye endorses Mentice appointing Frans Venker as its new CEO (effective 01 January 2025), some six...
Redeye gives initial comments on the acquisition by Tagmaster that was announced today.
Vi inleder bevakning på Acuvi, en teknikkoncern som utvecklar, tillverkar och säljer avancerade mikr...
Cereno Scientific has released its Q324 results, marking a productive and strategically significant ...
En utmanande solmarknad tillsammans med en svag byggkonjunktur har påverkat bolagets nettoomsättning...
Lipigons fas 2a-studie med triglyceridsänkaren Lipisense har inkluderat sin första patient, en vikti...
Analyst Group inleder analysbevakning på Neovici, vilket innefattar analysbevakning med bland annat ...
Redeye comments on MindArk’s Q3 results, which were weaker than expected in both sales and profitabi...
Endomines released a profit warning due to lower-than-expected production volume growth in Q4 driven...
Prolight continues to make progress with its proprietary Psyros platform, with a pre-validation stud...
CMD: Solid M&A runway, improved underlying profitability Increased confidence in 15% growth potentia...
Zoomability Int AB (”Zoomability” eller ”bolaget”) meddelade den 27 november att bolaget har testat ...
MoveByBike Europe AB (”MoveByBike” eller ”Bolaget”) publicerade den 26 november 2024 Bolagets kvarta...
Redeye provides a brief comment on Pepaxti's market access in Italy.
Fortsatt svag konsumentmarknad Omsättningen i det tredje kvartalet minskade med 13,3 procent, vilket...
Redeye comments on FluoGuide’s Q3 2024 report, following its recent business update on FG001’s plann...
First Venture Sweden (”First Venture” eller ”Bolaget”) är ett investmentbolag med fokus på snabbväxa...
SABCS (San Antonio Breast Cancer Symposium) is a major annual US cancer conference, and this year, B...
Redeye briefly comments on the positive news that Saniona has outlicensed SAN711 to Acadia in neurol...
